Robotics Stocks To Keep An Eye On - November 4th

Key Points

• Teradyne, Ouster, and PROCEPT BioRobotics were identified as robotics stocks to watch based on their recent dollar trading volume. They span automated testing and robotics, lidar sensors, and urologic surgical robotics.
• Teradyne shares fell $20.84 to $248.51 on Wednesday, while Ouster rose $4.44 to $33.42.
• PROCEPT BioRobotics gained $2.21 to $22.38; its shares traded near their 50-day moving average of $19.33 and below their 200-day average of $23.27.

Teradyne, Ouster, and PROCEPT BioRobotics are the three Robotics stocks to watch today, according to MarketBeat's stock screener tool. Robotics stocks are shares of publicly traded companies that develop, manufacture, or use robots, automation systems, artificial intelligence, and related technologies. For investors, these stocks represent an opportunity to gain exposure to the growth of industries such as manufacturing, healthcare, logistics, and autonomous systems, though they may also carry risks related to competition, regulation, high valuations, and technological change. These companies had the highest dollar trading volume of any Robotics stocks within the last several days.

Teradyne (TER)

Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

NASDAQ TER traded down $20.84 on Wednesday, reaching $248.51. 2,024,807 shares of the stock traded hands, compared to its average volume of 3,566,633. The company has a fifty day moving average price of $360.00 and a 200-day moving average price of $348.75. The company has a market cap of $38.80 billion, a price-to-earnings ratio of 28.59, a PEG ratio of 0.51 and a beta of 1.73. Teradyne has a 12 month low of $151.52 and a 12 month high of $487.91.

Read Our Latest Research Report on TER

Ouster (OUST)

Ouster, Inc. provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in Americas, the Asia-Pacific, Europe, the Middle East, and Africa. Its products include high-resolution scanning and solid-state digital lidar sensors, analog lidar sensors, and software solutions.

Shares of Ouster stock traded up $4.44 during trading on Wednesday, hitting $33.42. 3,991,997 shares of the stock traded hands, compared to its average volume of 3,065,434. The firm has a market cap of $2.41 billion, a P/E ratio of -38.77 and a beta of 3.47. Ouster has a 52-week low of $16.40 and a 52-week high of $63.79. The stock's fifty day simple moving average is $35.56 and its 200 day simple moving average is $32.43.

Read Our Latest Research Report on OUST

PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).

NASDAQ:PRCT traded up $2.21 during mid-day trading on Wednesday, reaching $22.38. The company's stock had a trading volume of 1,455,256 shares, compared to its average volume of 1,495,474. The company has a quick ratio of 5.35, a current ratio of 6.55 and a debt-to-equity ratio of 0.15. PROCEPT BioRobotics has a 1 year low of $16.67 and a 1 year high of $38.11. The stock has a fifty day moving average of $19.33 and a 200-day moving average of $23.27. The firm has a market capitalization of $1.28 billion, a PE ratio of -11.56 and a beta of 0.88.

Read Our Latest Research Report on PRCT

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.